CNS Disorders  >>  Qsymia (topiramate/phentermine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Qsymia (topiramate/phentermine) / IEH Biopharma, Alvogen
NCT02659475: Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

Completed
2
10
US
PHEN/TPM ER (Qsymia®)
Lindner Center of HOPE, University of Cincinnati
Binge Eating Disorder
07/16
09/16

Download Options